Billionaire Joel Greenblatt’s 5 Biggest Moves This Quarter Reveal a Surprising Defensive Shift

Joel Greenblatt’s Gotham Asset Management disclosed a defensive tilt in its Q2 2026 13F, filed in mid-August, headlined by a $2.65 billion add to the SPDR S&P 500 ETF and outsized conviction buys in managed care, packaged foods, and Manhattan office real estate. For a quant shop built on the “magic formula” framework, the shift toward index beta and staples is the tell. Greenblatt appears to be dialing down single-name risk and buying umbrellas.

The centerpiece move: SPDR S&P 500 ETF Trust (NYSEARCA:SPY) now anchors roughly 20% of the 1,791-position book. That is a striking allocation for a firm known for concentrated value screens. With SPY trading at $768.51 and up 13.31% year to date, the add functions as a hedge against factor drift while the fund reshuffles hundreds of smaller positions. Pair that with a new ~$157 million short-duration Treasury bill position, and the message is clear: dry powder and market beta over stock-picking alpha.

The Conviction Buys Behind the Shift

The most aggressive individual add was Humana (NYSE:HUM | HUM Price Prediction), where Gotham grew its share count roughly 65-fold. The thesis is visible in the numbers. Humana posted Q2 revenue growth of 26.2% year over year, individual Medicare Advantage membership climbed meaningfully year over year, and CEO Jim Rechtin reiterated the path to a “sustainable pre-tax margin of at least 3% in 2028.” The stock is up 51.18% year to date, and analysts carry a $416.43 target. Healthcare spending grew from $3,537.7B in June 2025 to $3,741.0B in June 2026, a textbook defensive tailwind.

General Mills (NYSE:GIS) saw a 4.4x share increase. This is a contrarian value bet: the stock is down 14.37% year to date, trades at a forward P/E of 13, and yields 6.22%. With consumer sentiment at recessionary levels of 49.5, staples exposure at trough multiples fits the playbook.

Vornado Realty Trust (NYSE:VNO) got a 3.2x add, a bet on the Manhattan office recovery. Vornado’s NY office occupancy climbed to 92.2%, and Chairman Steven Roth noted “Office leasing volume in Manhattan is at its highest level in 25 years.”

The outlier is KLA Corporation (NASDAQ:KLAC), up 8.5x. Semiconductor capital equipment is cyclical, so this looks less defensive and more like a valuation call on an AI infrastructure winner posting 42.5% operating margins and 87.5% return on equity.

Should Retail Follow?

The defensive skeleton makes sense. Sentiment is depressed, the VIX sits at 14.25 (complacency territory), and PCE growth is decelerating. Humana offers a clear operational turnaround with a hard 2028 margin target. General Mills offers yield and a trough valuation. Vornado offers real occupancy improvement at a 23% NAV discount. The SPY position is a hedge, not a thesis.

For a retirement-focused investor, the framework is instructive: pairing a market beta anchor with defensive cash flow names, holding dry powder in T-bills, and treating concentrated cyclicals like KLAC as satellite positions. Among the four conviction adds, HUM stands out where the setup, valuation, and demographic tailwind align most cleanly.

Contact [email protected] for any questions or corrections.